TRDA20270115P2.5
TRDA Jan 15 2027 2.50 Put (TRDA270115P00002500)
option OPRA

entrada therapeutics is building the leading intracellular biologics company to transform the treatment of devastating diseases. entrada was co-founded in 2016 by 5am ventures, a leading life sciences venture capital firm.